MMP-2-Potential Predictor of Epithelial-Mesenchymal Transition in Squamous Cell Carcinogenesis
- PMID: 40724562
- PMCID: PMC12300701
- DOI: 10.3390/life15071060
MMP-2-Potential Predictor of Epithelial-Mesenchymal Transition in Squamous Cell Carcinogenesis
Abstract
Epithelial-mesenchymal transition (EMT) is one of the key steps in cutaneous carcinogenesis. At the molecular level, this cellular dedifferentiation is modulated by the interaction of signalling pathways that favour basement membrane degradation under the influence of proinflammatory cytokines and matrix metalloproteinases (MMPs). Given the intricate role of these endopeptidases in modulating extracellular matrix turnover, the present study aimed primarily to identify the MMP-2 expression profile during the early stages of cutaneous malignant transformation. Forty-eight lesions with malignant transformation potential were excised in healthy tissue. Following the histopathological diagnosis of keratoacanthoma, Bowen's disease and actinic keratosis, the biological preparations were deparaffinised and homogenised in order to perform the FRET technique using the "MMP-2 Assay Kit Fluorometric". The results of the previous part of this research indicate that MMP-2 expression is more intense in lesions of actinic keratosis compared to normal tissues and to keratoacanthoma or Bowen's disease lesions, inversely proportional to the histopathological degree of dysplasia. Monitoring metalloproteinase activity in dysplastic epithelium may improve the detection of malignant transformation and guide treatment decisions.
Keywords: MMP-2; carcinogenesis; epithelial–mesenchymal transition; premalignant skin lesions.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Interventions for cutaneous Bowen's disease.Cochrane Database Syst Rev. 2013 Jun 24;2013(6):CD007281. doi: 10.1002/14651858.CD007281.pub2. Cochrane Database Syst Rev. 2013. PMID: 23794286 Free PMC article.
-
Proteolysis of the pericellular matrix: Pinpointing the role and involvement of matrix metalloproteinases in early osteoarthritic remodeling.Acta Biomater. 2024 Jun;181:297-307. doi: 10.1016/j.actbio.2024.05.002. Epub 2024 May 6. Acta Biomater. 2024. PMID: 38710401
-
Chondroitin sulfate proteoglycan 4 increases invasion of recessive dystrophic epidermolysis bullosa-associated cutaneous squamous cell carcinoma by modifying transforming growth factor-β signalling.Br J Dermatol. 2024 Dec 23;192(1):104-117. doi: 10.1093/bjd/ljae295. Br J Dermatol. 2024. PMID: 39018437 Free PMC article.
-
Immunohistochemical expression of matrix metalloproteinase-9 and 13 in oral squamous cell carcinoma and their role in predicting lymph node metastasis.World J Methodol. 2025 Jun 20;15(2):94514. doi: 10.5662/wjm.v15.i2.94514. eCollection 2025 Jun 20. World J Methodol. 2025. PMID: 40548219 Free PMC article.
-
Matrix metalloproteinase-driven epithelial-mesenchymal transition: implications in health and disease.J Transl Med. 2025 Apr 11;23(1):436. doi: 10.1186/s12967-025-06447-w. J Transl Med. 2025. PMID: 40217300 Free PMC article. Review.
References
-
- Azimi A., Yang P., Ali M., Howard V., Mann G.J., Kaufman K.L., Fernandez-Penas P. Data Independent Acquisition Prote-omic Analysis Can Discriminate between Actinic Keratosis, Bowen’s Disease, and Cutaneous Squamous Cell Carcinoma. J. Investig. Dermatol. 2020;140:212–222. doi: 10.1016/j.jid.2019.06.128. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous